Theravance Biopharma, Inc. (TBPH)
14.70
-0.05
(-0.34%)
USD |
NASDAQ |
Mar 24, 12:05
Theravance Biopharma Market Cap : 750.71M for March 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Integer Holdings Corp. | 2.921B |
| QuidelOrtho Corp. | 1.134B |
| Viatris, Inc. | 15.43B |
| Catalyst Pharmaceuticals, Inc. | 2.825B |
| Nektar Therapeutics | 1.231B |
Market Cap Related Metrics
| PE Ratio | 7.250 |
| PS Ratio | 7.024 |
| Price to Book Value | 2.530 |
| Price to Free Cash Flow | 3.165 |
| Price | 14.70 |
| Earnings Yield | 13.79% |
| Normalized PE Ratio | 7.250 |